Davide Cucchi

Dr. Davide Cucchi

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
PRPietro Randelli
Pietro Randelli
FRFilippo Randelli
Filippo Randelli
VRVincenza Ragone
Vincenza Ragone
AMAlessandra Menon
Alessandra Menon
RDRiccardo D'Ambrosi
Riccardo D'Ambrosi
Giuseppe BanfiGiuseppe Banfi
Giuseppe Banfi
Rotator cuff injuries are a common source of shoulder pathology and result in an important decrease in quality of patient life. Given the frequency of these injuries, as well as the relatively poor result of surgical intervention, it is not surprising that new and innovative strategies like tissue engineering have become more appealing. Tissue-engineering strategies involve the use of cells and/or bioactive factors to promote tendon regeneration via natural processes. The ability of numerous growth factors to affect tendon healing has been extensively analyzedin vitroand in animal models, showing promising results. Platelet-rich plasma (PRP) is a whole blood fraction which contains several growth factors. Controlled clinical studies using different autologous PRP formulations have provided controversial results. However, favourable structural healing rates have been observed for surgical repair of small and medium rotator cuff tears. Cell-based approaches have also been suggested to enhance tendon healing. Bone marrow is a well known source of mesenchymal stem cells (MSCs). Recently,ex vivohuman studies have isolated and cultured distinct populations of MSCs from rotator cuff tendons, long head of the biceps tendon, subacromial bursa, and glenohumeral synovia. Stem cells therapies represent a novel frontier in the management of rotator cuff disease that required further basic and clinical research.

24 March 2017 in Knee Surgery, Sports Traumatology, Arthroscopy
Verified
Journal Article
Closed access
PDF file
PAPaolo Arrigoni
Paolo Arrigoni
DCDavide Cucchi
Davide Cucchi
RDRiccardo D'Ambrosi
Riccardo D'Ambrosi
UBUsman Butt
Usman Butt
MSMarc R. Safran
Marc R. Safran
PRPietro Randelli
Pietro Randelli

11 December 2017 in Joints
Verified
Journal Article
Open access
PDF file
DCDavide Cucchi
Davide Cucchi
AMAntongiulio Marmotti
Antongiulio Marmotti
SGSilvana De Giorgi
Silvana De Giorgi
ACAlberto Costa
Alberto Costa
RDRocco D'APolito
Rocco D'APolito
SCSIGASCOT Research Committee
SIGASCOT Research Committee
Shoulder stiffness is a condition of painful restriction of the glenohumeral range of motion. Numerous risk factors for primary and postoperative shoulder stiffness have been described. This article summarizes the known aspects of the pathophysiology of shoulder stiffness, with special attention to elements of molecular biology and genetics, which could influence the risk of developing shoulder stiffness. Furthermore, the role of hormonal and metabolic factors, medical disorders, drugs, and of other published risk factors for primary and postoperative shoulder stiffness is reviewed and discussed. Finally, aspects related to shoulder surgery and postoperative rehabilitation protocols, which could influence the development of postoperative stiffness are presented.

2 December 2014 in Knee Surgery, Sports Traumatology, Arthroscopy
Verified
Journal Article
Closed access
PDF file
PRPietro Randelli
Pietro Randelli
DCDavide Cucchi
Davide Cucchi
VRVincenza Ragone
Vincenza Ragone
LGLaura de Girolamo
Laura de Girolamo
PCPaolo Cabitza
Paolo Cabitza
MRMario Randelli
Mario Randelli

22 August 2014 in Knee Surgery, Sports Traumatology, Arthroscopy
Verified
Journal Article
Closed access
PDF file
PSPietro Spennacchio
Pietro Spennacchio
Giuseppe BanfiGiuseppe Banfi
Giuseppe Banfi
DCDavide Cucchi
Davide Cucchi
RDRiccardo D'Ambrosi
Riccardo D'Ambrosi
PCPaolo Cabitza
Paolo Cabitza
PRPietro Randelli
Pietro Randelli

18 March 2022 in The American Journal of Sports Medicine
Verified
Journal Article
Closed access
PRPietro S. Randelli
Pietro S. Randelli
DCDavide Cucchi
Davide Cucchi
CFChiara Fossati
Chiara Fossati
LBLinda Boerci
Linda Boerci
ENElisabetta Nocerino
Elisabetta Nocerino
AMAlessandra Menon
Alessandra Menon
Background: Autologous microfragmented lipoaspirate tissue has been recently introduced in orthopaedics as an easily available source of nonexpanded adipose-derived mesenchymal stem cells. Autologous microfragmented lipoaspirate tissue is expected to create a suitable microenvironment for tendon repair and regeneration. Rotator cuff tears show a high incidence of rerupture and represent an ideal target for nonexpanded mesenchymal stem cells. Purpose: To evaluate the safety and efficacy of autologous lipoaspirate tissue in arthroscopic rotator cuff repair. Study Design: Randomized controlled trial; Level of evidence, 2. Methods: Consecutive patients referring to the investigation center for surgical treatment of magnetic resonance imaging–confirmed degenerative posterosuperior rotator cuff tears were assessed for eligibility. Those who were included were randomized to receive a single-row arthroscopic rotator cuff repair, followed by intraoperative injection of autologous microfragmented adipose tissue processed with an enzyme-free technology (treatment group) or not (control group). Clinical follow-up was conducted at 3, 6, 12, 18, and 24 months; at 18 months after surgery, magnetic resonance imaging of the operated shoulder was obtained to assess tendon integrity and rerupture rate. Results: An overall 177 patients were screened, and 44 (22 per group) completed the 24-month follow-up. A statistically significant difference in favor of the treatment group in terms of Constant-Murley score emerged at the primary endpoint at 6-month follow-up (mean ± SD; control group, 76.66 ± 10.77 points; treatment group, 82.78 ± 7.00 points; P = .0050). No significant differences in clinical outcome measures were encountered at any of the other follow-up points. No significant differences emerged between the groups in terms of rerupture rate, complication rate, and number of adverse events. Conclusion: This prospective randomized controlled trial demonstrated that the intraoperative injection of autologous microfragmented adipose tissue is safe and effective in improving short-term clinical and functional results after single-row arthroscopic rotator cuff repair. Registration: NCT02783352 (ClinicalTrials.gov identifier).